Business Standard

Monday, January 20, 2025 | 07:40 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Annual Covid-19 vax preferred to frequent boosters, says Pfizer CEO

Albert Bourla has said Pfizer could be ready to file for approval for a redesigned vaccine to fight Omicron, and mass produce it, as soon as March

Photo courtesy: Reuters
Premium

Photo: Reuters

Reuters
Pfizer Inc Chief Executive Albert Bourla has said that an annual Covid-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic.

Pfizer/BioNtech's Covid-19 vaccine has shown to be effective against severe disease and death caused by the heavily-mutated Omicron variant but less effective in preventing transmission.

With cases soaring, some countries have expanded Covid-19 vaccine booster programmes or shortened the gap between shots as governments scramble to shore up protection.

In an interview with Israel's N12 News, Bourla was asked whether he sees booster shots being administered every four to five months

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in